|
US20030105294A1
(en)
*
|
1998-02-25 |
2003-06-05 |
Stephen Gillies |
Enhancing the circulating half life of antibody-based fusion proteins
|
|
US20050202538A1
(en)
*
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
|
HUP0204475A2
(en)
|
2000-02-11 |
2003-04-28 |
Merck Patent Gmbh |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
RU2003129528A
(ru)
|
2001-03-07 |
2005-04-10 |
Мерк Патент ГмбХ (DE) |
Способ экспрессии белков, содержащих в качестве компонента гибридный изотип антитела
|
|
WO2002079415A2
(en)
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
|
EP1383785B1
(en)
|
2001-05-03 |
2011-03-16 |
Merck Patent GmbH |
Recombinant tumor specific antibody and use thereof
|
|
DK1454138T3
(da)
|
2001-12-04 |
2012-02-13 |
Merck Patent Gmbh |
Immunocytokiner med moduleret selektivitet
|
|
ES2305886T3
(es)
*
|
2003-12-30 |
2008-11-01 |
Merck Patent Gmbh |
Proteinas de fusion de il-7 con porciones de anticuerpo, su preparacion y su empleo.
|
|
RU2370276C2
(ru)
*
|
2003-12-31 |
2009-10-20 |
Мерк Патент Гмбх |
Fc-ЭРИТРОПОЭТИН СЛИТЫЙ БЕЛОК С УЛУЧШЕННОЙ ФАРМАКОКИНЕТИКОЙ
|
|
US7670595B2
(en)
*
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
|
US20070104689A1
(en)
*
|
2005-09-27 |
2007-05-10 |
Merck Patent Gmbh |
Compositions and methods for treating tumors presenting survivin antigens
|
|
AR058135A1
(es)
|
2005-10-21 |
2008-01-23 |
Chugai Pharmaceutical Co Ltd |
Agentes para el tratamiento de cardiopatias
|
|
ATE550353T1
(de)
|
2005-12-30 |
2012-04-15 |
Merck Patent Gmbh |
Die bindung von mit il-6ralpha komplexiertem il-6 an gp130 verhindernde anti-il-6-antikörper
|
|
JP5754875B2
(ja)
|
2006-04-07 |
2015-07-29 |
国立大学法人大阪大学 |
筋再生促進剤
|
|
TW200831528A
(en)
|
2006-11-30 |
2008-08-01 |
Astrazeneca Ab |
Compounds
|
|
ES2433380T3
(es)
*
|
2006-11-30 |
2013-12-10 |
Medimmune Limited |
Anticuerpos específicos para el complejo de interleucina 6 y el receptor de interleucina 6
|
|
TWI438208B
(zh)
|
2007-01-23 |
2014-05-21 |
中外製藥股份有限公司 |
抑制慢性排斥反應之藥劑
|
|
US8062864B2
(en)
|
2007-05-21 |
2011-11-22 |
Alderbio Holdings Llc |
Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
|
|
US8404235B2
(en)
|
2007-05-21 |
2013-03-26 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
|
US8252286B2
(en)
|
2007-05-21 |
2012-08-28 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
|
US7906117B2
(en)
|
2007-05-21 |
2011-03-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
|
|
US8178101B2
(en)
|
2007-05-21 |
2012-05-15 |
Alderbio Holdings Inc. |
Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
|
|
DK2164514T3
(en)
|
2007-05-21 |
2017-02-27 |
Alderbio Holdings Llc |
Antibodies to IL-6 and its use
|
|
US9701747B2
(en)
|
2007-05-21 |
2017-07-11 |
Alderbio Holdings Llc |
Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
|
|
WO2009109584A1
(en)
*
|
2008-03-07 |
2009-09-11 |
Ferring International Center S. A. |
ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX
|
|
MX2010012031A
(es)
*
|
2008-05-13 |
2011-01-20 |
Novimmune Sa |
Anticuerpos anti-il-6/il-6r y metodos de uso de los mismos.
|
|
CA2728243C
(en)
|
2008-06-05 |
2020-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Il-6 inhibitor for suppressing neuroinvasion in pancreatic cancer
|
|
US8188235B2
(en)
|
2008-06-18 |
2012-05-29 |
Pfizer Inc. |
Antibodies to IL-6 and their uses
|
|
MX2011000071A
(es)
*
|
2008-07-02 |
2011-05-03 |
Emergent Product Dev Seattle |
Inmunoterapeuticos de interleucina-6 (il6).
|
|
CN102316898A
(zh)
*
|
2008-09-29 |
2012-01-11 |
森托科尔奥索生物科技公司 |
抗cd147抗体、方法和用途
|
|
US8420089B2
(en)
|
2008-11-25 |
2013-04-16 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
|
US8992920B2
(en)
|
2008-11-25 |
2015-03-31 |
Alderbio Holdings Llc |
Anti-IL-6 antibodies for the treatment of arthritis
|
|
US8323649B2
(en)
|
2008-11-25 |
2012-12-04 |
Alderbio Holdings Llc |
Antibodies to IL-6 and use thereof
|
|
US8337847B2
(en)
|
2008-11-25 |
2012-12-25 |
Alderbio Holdings Llc |
Methods of treating anemia using anti-IL-6 antibodies
|
|
KR20110112307A
(ko)
*
|
2008-11-25 |
2011-10-12 |
앨더 바이오파마슈티컬즈, 인코포레이티드 |
알부민을 상승시키고 및／또는 ｃｒｐ를 낮추는 ｉｌ６의 길항제
|
|
US9452227B2
(en)
|
2008-11-25 |
2016-09-27 |
Alderbio Holdings Llc |
Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
|
|
US9212223B2
(en)
|
2008-11-25 |
2015-12-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
|
SG175233A1
(en)
|
2009-04-22 |
2011-11-28 |
Merck Patent Gmbh |
Antibody fusion proteins with modified fcrn binding sites
|
|
NZ621170A
(en)
|
2009-05-13 |
2015-08-28 |
Genzyme Corp |
Anti-human cd52 immunoglobulins
|
|
WO2011006273A1
(en)
*
|
2009-07-15 |
2011-01-20 |
Eva Kovacs-Benke |
Combination of a human interleukin-6 antagonist and a human interleukin-6 receptor antagonist in therapy of tumour diseases
|
|
WO2011013786A1
(ja)
*
|
2009-07-31 |
2011-02-03 |
Maeda Shin |
癌の転移抑制剤
|
|
CN102597001B
(zh)
*
|
2009-08-19 |
2014-07-30 |
默克专利有限公司 |
在ffpe材料中用于检测整联蛋白复合体的抗体
|
|
US9775921B2
(en)
|
2009-11-24 |
2017-10-03 |
Alderbio Holdings Llc |
Subcutaneously administrable composition containing anti-IL-6 antibody
|
|
CN102740888B
(zh)
|
2009-11-24 |
2016-10-12 |
奥尔德生物制药公司 |
Il-6抗体及其用途
|
|
WO2011079308A2
(en)
|
2009-12-23 |
2011-06-30 |
Emergent Product Development Seattle, Llc |
Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof
|
|
WO2011149051A1
(ja)
|
2010-05-28 |
2011-12-01 |
中外製薬株式会社 |
抗腫瘍t細胞応答増強剤
|
|
CA2818813C
(en)
|
2010-11-23 |
2020-10-06 |
Alder Biopharmaceuticals, Inc. |
Anti-il-6 antibodies for the treatment of oral mucositis
|
|
EP2726506A1
(en)
|
2011-05-27 |
2014-05-07 |
Dutalys |
Removal of monomeric targets
|
|
EP2723380B1
(en)
|
2011-06-24 |
2019-08-21 |
Stephen D. Gillies |
Light chain immunoglobulin fusion proteins and methods of use thereof
|
|
US20140315956A1
(en)
*
|
2011-07-29 |
2014-10-23 |
Nationwide Children's Hospital |
Small molecule inhibitors of il-6 and uses thereof
|
|
WO2013059548A1
(en)
*
|
2011-10-19 |
2013-04-25 |
Sanofi |
Compositions and methods for treating cancer using jak2 inhibitor
|
|
CN104903349B
(zh)
*
|
2012-11-08 |
2018-10-19 |
十一生物治疗股份有限公司 |
Il-6拮抗剂及其应用
|
|
EP2970496B1
(en)
|
2013-03-12 |
2018-07-18 |
Institute of Arthritis Research LLC |
Immunologically active polypeptide
|
|
AR095199A1
(es)
|
2013-03-15 |
2015-09-30 |
Genzyme Corp |
Anticuerpos anti-cd52
|
|
CN120904322A
(zh)
|
2013-09-13 |
2025-11-07 |
豪夫迈·罗氏有限公司 |
包含纯化的重组多肽的方法和组合物
|
|
RU2016107435A
(ru)
*
|
2013-09-13 |
2017-10-18 |
Дженентек, Инк. |
Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты
|
|
CN103897061B
(zh)
*
|
2014-03-25 |
2017-06-16 |
宝船生物医药科技(上海)有限公司 |
阻断西妥昔单抗和egfr结合的抗体、其试剂盒及杂交瘤细胞
|
|
TWI713453B
(zh)
|
2014-06-23 |
2020-12-21 |
美商健生生物科技公司 |
干擾素α及ω抗體拮抗劑
|
|
JP6594438B2
(ja)
*
|
2014-11-07 |
2019-10-23 |
セセン バイオ， インコーポレイテッド |
改善されたｉｌ−６抗体
|
|
DK3227325T3
(da)
*
|
2014-12-01 |
2024-07-08 |
Ferring Bv |
Sammensætninger med selektive hæmmere af il-6-trans-signalering
|
|
HRP20210737T1
(hr)
*
|
2014-12-01 |
2021-06-11 |
Ferring B.V. |
Primjena selektivnog inhibitora il-6-trans-signalizacije
|
|
EP3317269B1
(en)
|
2015-07-02 |
2022-09-21 |
F. Hoffmann-La Roche AG |
Bicyclic lactams as receptor-interacting protein-1 (rip1) kinase inhibitors for treating e.g. inflammatory diseases
|
|
CN108718522A
(zh)
|
2016-02-23 |
2018-10-30 |
赛森生物股份有限公司 |
Il-6拮抗剂制剂及其用途
|
|
WO2018073193A1
(en)
|
2016-10-17 |
2018-04-26 |
F. Hoffmann-La Roche Ag |
Bicyclic pyridone lactams and methods of use thereof
|
|
US11072607B2
(en)
|
2016-12-16 |
2021-07-27 |
Genentech, Inc. |
Inhibitors of RIP1 kinase and methods of use thereof
|
|
KR20200012823A
(ko)
|
2017-02-01 |
2020-02-05 |
예일 유니버시티 |
이뇨제 내성의 치료
|
|
WO2018203545A1
(ja)
|
2017-05-02 |
2018-11-08 |
国立研究開発法人国立精神・神経医療研究センター |
Ｉｌ－６及び好中球の関連する疾患の治療効果の予測及び判定方法
|
|
JP7235249B2
(ja)
|
2017-10-20 |
2023-03-08 |
学校法人兵庫医科大学 |
抗ｉｌ－６受容体抗体を含有する術後の癒着を抑制するための医薬組成物
|
|
CN109867723B
(zh)
*
|
2017-12-05 |
2022-06-17 |
南京金斯瑞生物科技有限公司 |
抗人il6单克隆抗体及其制备方法和用途
|
|
EP3735421A4
(en)
|
2018-01-05 |
2021-09-22 |
Corvidia Therapeutics, Inc. |
METHOD OF TREATMENT OF IL-6 MEDIATED INFLAMMATION WITHOUT IMMUNSUPPRESSION
|
|
WO2019151418A1
(ja)
|
2018-01-31 |
2019-08-08 |
元一 加藤 |
Ｉｌ－６阻害剤を含有する喘息の治療剤
|
|
WO2019204537A1
(en)
|
2018-04-20 |
2019-10-24 |
Genentech, Inc. |
N-[4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol e-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs)
|
|
EP3957324A4
(en)
|
2019-04-17 |
2023-02-08 |
Hiroshima University |
THERAPEUTIC FOR UROLOGICAL ONCOLOGY CHARACTERIZED BY BEING ADMINISTRATED IN COMBINATION WITH IL-6 INHIBITOR AND CCR2 INHIBITOR
|
|
CN114375205A
(zh)
|
2019-06-20 |
2022-04-19 |
武田药品工业株式会社 |
用基于病毒的基因疗法进行治疗的方法
|
|
CN111057152B
(zh)
*
|
2019-12-11 |
2022-03-11 |
中国人民解放军第四军医大学 |
一种抗人IL-6Ra单克隆抗体及其应用
|
|
JP2023042974A
(ja)
*
|
2021-09-15 |
2023-03-28 |
シスメックス株式会社 |
抗サイトカイン抗体の抗原に対する親和性を向上させる方法、抗サイトカイン抗体の製造方法及び抗サイトカイン抗体
|
|
CN119080929B
(zh)
*
|
2023-06-05 |
2025-08-12 |
东莞市朋志生物科技有限公司 |
抗白介素6抗体、检测白介素6的试剂和试剂盒
|